Post-Marketing Surveillance Study of Tolvaptan in Patients With ADPKD

NCT02847624 · clinicaltrials.gov ↗

COMPLETED

Status

1802

Enrollment

INDUSTRY

Sponsor class

Conditions

Polycystic Kidney, Autosomal Dominant

Interventions

DRUG: tolvaptan

Sponsor

Otsuka Pharmaceutical Co., Ltd.